다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/02/12	22:26	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/11	22:32	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/11	21:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/11	06:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/11	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/11	02:13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/02/03	06:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 10, 2021	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/01/26	06:51	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/12/02	21:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/12/02	08:22	PR Newswire (US)	FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/10/29	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/10/29	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/10/27	05:01	PR Newswire (US)	Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/10/22	05:45	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on October 28, 2020	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/09/01	07:30	PR Newswire (US)	Vanda Pharmaceuticals Provides Update on Tradipitant Development Program	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/22	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/18	20:00	PR Newswire (US)	Vanda Pharmaceuticals' Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients ...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/18	05:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/15	05:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/06	20:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/06	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/06	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2020 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/08/03	20:00	PR Newswire (US)	FDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZ® (tasimelteon) in the Treatment of Smith-Magenis ...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/07/30	06:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/07/14	05:30	PR Newswire (US)	FDA grants authorization for Individual Patient Expanded Access Protocol for the use of tradipitant for gastroparesis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/16	08:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/16	08:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/16	08:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/16	08:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/16	08:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 다음 >>

US Dollar vs Yen

Deutsche Telekom (QX)

JP Morgan Chase

BNP Paribas (QX)

Invesco QQQ Trust Series 1

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관